LSD (lysergic corrosive diethylamide), a compound whose psychoactive properties were found by Dr. Albert Hofmann on April 19, 1943. Psilocybin is a hallucinogenic compound tracked down in hallucinogenic mushrooms (likewise found by Hofmann). Psilocybin mushrooms have been utilized for millennia by native societies for various strict and remedial purposes.
The profound individual and frequently otherworldly encounters empowered by the cautious utilization of psilocybin and LSD are notable. MAPS is keen on these substances for their capability to assist individuals with different circumstances, zeroing in essentially on the treatment of uneasiness related with perilous ailment.
There has been significant examination showing the security and adequacy of LSD for treating uneasiness in disease patients, yet a lot of this exploration was directed quite a long time back. MAPS is growing new exploration conventions that satisfy current medication advancement guidelines. Our pilot LSD and psilocybin studies will be utilized to direct the advancement of future treatment philosophies.